"Last year, we invested around Rs 85 crore in setting up a new facility and now we are planning to invest another Rs 80 crore in further expanding our capacity," Marck Biosciences Ltd Managing Director Bhavesh Patel told PTI.
The company has recently entered the Latin American market, after receiving Brazilian healthcare watchdog ANVISA approval for sterile injectibles exports to Brazil and is now talking to the various pharmaceutical companies based in US and Europe for the partnership ventures.
The company has already invested Rs 85 crore in setting up a new manufacturing unit in Gujarat and is now infusing another 80 crore to meet the expected demands from the overseas market as it plans to have its presence in overseas market.
Explaining the company's plan in US and Europe, Patel said, "We have different business model for US and Europe."
